Stereochemistry as a major determinant of the anti-HIV activity of chiral naphthyl thiourea compounds

Antiviral Chemistry and Chemotherapy

Volumn 12, Issue 4, 2001, Pages 213-221

  Venkatachalam, T K ^a   Mao, C ^a   Uckun, F M ^a  

^a PARKER HUGHES INSTITUTE   (United States)

Author keywords

HIV; Non nucleoside inhibitor; Stereochemistry; Thiourea

Indexed keywords

N (1 NAPTHYLETHYL) N' [2 (6 METHYLPYRIDYL)]THIOUREA; N [1 (NAPHTHYL)ETHYL] N' [2 (5 CHLOROPYRIDYL)]THIOUREA; NEVIRAPINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; ARTICLE; DRUG EFFICACY; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOMER; GEOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IC 50; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; STEREOCHEMISTRY; STEREOISOMERISM; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; VIRUS INHIBITION; VIRUS ISOLATION;

EID: 0035197888     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632020101200402     Document Type: Article

References (22)

1. Phenethylthiazolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and basic structure-activity relationship studies of PETT analogs
2. Phenethylthiazolykhiourea (PETT) compounds as a new class of HIV-1 reverse transcriptase inhibitors. 2. Synthesis and further structure-activity relationship studies of PETT analogs
3. Evaluation of the pharmocokinetic features and tissue distribution of the potent nonnucleoside inhibitor of HIV-1 reverse transcriptase, N-[2-(2-fluorophenethyl)]-N′ [2-(5-bromopyridyl)]-thiourea (HI-240) with an analytical HPLC method
4. In vivo toxicity, pharmocokinetic features and tissue distribution of N-[2,5-dimethoxyphenylethyl)]-N′-[2-(5-bromopyridyl)]-thiourea (HI-236), a potent non-nucleoside inhibitor of HIV-1 reverse transcriptase
5. HIV inhibitors targeted at the reverse transcriptase
6. The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection
7. The molecular biology of human immunodeficiency virus type 1 infections
8. Structure-based design of N-[2-(1-piperidinylethyl)-N′-[2-(5-bromopyridyl)]-thiourea and N-[2-(1-piperazinylethyl)-N′-[2-(5-bromopyridyl)]-thiourea as potent non-nucleoside inhibitors of HIV-1 reverse transcriptase
9. Rational design of N-[2-(2,5-dimethoxyphenylethyl)]-N′-[2-(5-bromopyridyl)]-thiourea (HI-236) as a potent non-nucleoside inhibitor of drug-resistant human immunodeficiency virus
10. Structure-based design of non-nucleoside reverse transcriptase inhibitors of drug-resistant human immunodeficiency virus
11. Structure-based drug design of non-nucleoside inhibitors for wild-type and drug-resistant HIV reverse transcriptase
12. Molecular targets for AIDS therapy
13. TXU(anti-CD7)-pokeweed antiviral protein as a potent inhibitor of human immunodeficiency virus
14. N-[2-(1-cyclohexenyl)ethyl]-N′[2-(5-bromopyridyl)]-thiourea and N′-[2-(1-cyclohexenyl)ethyl]N′-[2-(5-chloropyridyl)]-thiourea as potent inhibitors of multidrug-resistant human immunodeficiency virus-1
15. N-[2-(2-thiophene) ethyl]-N′[2-(5-bromopyridyl)] thiourea as a potent inhibitor of NNI-resistant and multidrug-resistant human immunodeficiency virus-1
16. N′-[2-(4-methylphenyl)ethyl]-N′[2-(5-bromopyridyl)]- thiourea as a potent inhibitor of NNI-resistant and multidrug-resistant human immunodeficiency virus-1
17. Piperidinylethyl, phenoxyethyl, and fluoroethyl bromopyridyl thiourea compounds with potent anti-HIV activity
18. Stereochemistry of halopyridyl and thiazolyl thiourea compounds is a major determinant of their potency as non nucleoside inhibitors of HIV-1 reverse transcriptase
19. Anti-HIV activity of aromatic and heterocyclic thiazolyl thiourea compounds
20. 5-Alkyl-2-[(methylthiomethyl)thio]-6-(benzyl)-pyrimidin-4-(1H)-ones as potent non-nucleoside reverse transcriptase inhibitors of S-DABO series
21. Rational Design and Synthesis of phenethyl-5-bromopyridyl thiourea derivatives as potent non-nucleoside inhibitors of HIV reverse transcriptase
22. Inhibition of HIV replication by pokeweed antiviral protein targeted to CD4+ cells by monoclonal antibodies